Established respiratory conditions—including asthma across the lifespan, chronic obstructive pulmonary disease (COPD), chronic rhinosinusitis, allergic rhinitis, and refractory chronic cough—remain amongst the most prevalent chronic diseases globally. Each presents distinct diagnostic, management, and treatment optimisation challenges that reflect the complexity of respiratory care across diverse patient populations. With expanding therapeutic options, evolving treatment guidelines, and growing recognition of disease phenotypes, robust real-world evidence is essential for understanding disease burden, validating treatment approaches, supporting healthcare access decisions, and ensuring patient voices are central to respiratory innovation.
Adelphi Real World’s Established Respiratory Specific Programmes (DSPs) are purpose-designed to deliver this evidence.
Translating Respiratory Health Evidence into Action
Our Respiratory DSPs generate robust, actionable real-world insights across the full spectrum of pulmonary conditions. By engaging both specialist pulmonologists and patients, our DSPs deliver in-depth, clinically relevant perspectives on:
Condition Recognition & Clinical Pathways
Understand how respiratory specialists diagnose and manage established conditions—capturing diagnostic approaches, disease severity assessment, and treatment initiation pathways in routine clinical practice.
Treatment Selection & Therapeutic Strategies
Benchmark real-world therapy patterns: how clinicians choose and optimise treatments – from first-line options through advanced biologics and combination approaches – across adult asthma, severe asthma, paediatric asthma, COPD, chronic rhinosinusitis, allergic rhinitis, and refractory chronic cough.
Symptom Burden & Disease Impact
Explore condition-specific impacts: symptom severity, functional limitations, exacerbation frequency, airflow obstruction, psychological burden, work productivity, and quality-of-life consequences for patients and families.
Unmet Needs & Care Gaps
Identify areas where current management is inadequate, diagnostic delays persist, treatment barriers exist, phenotype recognition display challenges, and opportunities for therapeutic innovation in respiratory care are highlighted.
Established Respiratory Conditions Disease Specific Programmes (DSP) Portfolio
Why Partner with Adelphi Real World for Respiratory Research?
Respiratory Specialisation
Deep expertise across asthma, COPD, chronic rhinosinusitis, allergic rhinitis, and refractory chronic cough in adult and paediatric populations.
Authentic Clinician Networks
Access to pulmonologists, respiratory physicians, allergists, ear, nose and throat specialists, general practitioners, and respiratory nurses across diverse care settings.
Patient-Centred Approach
Evidence prioritising the lived experience of respiratory patients, including functional, psychological, and quality-of-life impacts.
Comprehensive Condition Coverage
Intelligence spanning common obstructive airway diseases, inflammatory airway conditions, and chronic cough across the patient lifespan.
Rigorous Methodology
Robust data collection capturing both clinical outcomes and patient-reported experiences specific to respiratory conditions.
Strategic Intelligence
Evidence supporting clinical development, reimbursement, and healthcare provider engagement in respiratory care.
Current Countries Respiratory DSPs Cover
Who We Collaborate With
We partner with pharmaceutical innovators, respiratory centres of excellence, pulmonary organisations, patient advocacy groups, and healthcare commissioners to advance respiratory research and improve outcomes for patients with established respiratory conditions globally.
Ready to Explore Our Respiratory Expertise?
-
Schedule a Consultation: Meet with our respiratory specialists to explore how our real-world evidence supports your respiratory programmes.
-
Learn About Our Approach: Interested in our clinician networks, global reach, condition expertise, or patient-centred methodology? Contact us for comprehensive information.
Established respiratory conditions deserve research partners who understand their complexity and prioritise the authentic experiences of patients. Adelphi Real World brings specialist expertise, authentic practitioner and patient networks, and rigorous methodology grounded in respiratory realities. Let’s collaborate to generate evidence that drives innovation and better outcomes for respiratory health.
Contact us today using the form below.
Eosinophils DSPs
Conferences Attending